Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the Third quarter of 2019 at the end of 30th September 2019 as
results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
Microsoft Word - MD_A_Q3_2019_EN 1 GLOCON.061/2019 November 11th, 2019 Subject Management’s analysis for the 3rd quarter of 2019 Attn. The President The Stock Exchange of Thailand Management’s
(Ending September 30, 2019) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial for Q3
Page 1 No. CMC Sor Lor.013/2019 Date 12 November 2019 Re: Management Discussion & Analysis for the Period Ended 30 September 2019 To The President of the Stock Exchange of Thailand (SET
GUIDELINES FRC Investor Listing Standards Proposal: Recommendations for Stock Exchange CERES ผู้ประกอบวิชาชีพ/ Gatekeepe r เรื่อง หน่วยงาน Corporate Secretaries เลขานุการบริษัท CSIA แนวปฏิบัติการ
Ref: ACC6405/001 March 12, 2021 Subject Clarification of the operating results for the quarter 1/2021 ended March 31, 2021 Attention: Director and Manager The Stock Exchange of Thailand According to
No. ADD-IR2021/001 19 May 2021 Subject: Management discussion and analysis for the performance for the three-month period ended 31 March 2021 To: President The Stock Exchange of Thailand AddTech Hub
Page 1 of 3 No. ACC6502/005 February 28, 2022 Subject: Clarification of the operating results Year 2021 of the year ended December 31, 2021 Attention : Director and Managing Director, The Stock
involved with the audit of an entity whose securities are publicly traded in stock exchange in your jurisdiction as either Signing Partner or Engagement Partner or equivalence? Yes No If yes, please attach